19809

    0

    MAITREYA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    MAITREYA MEDICARE LIMITED Share Price Today

    MAITREYA MEDICARE LIMITED is currently trading at ₹123.55, down by ₹3.19 from the previous close. The stock touched an intraday high of ₹131.40 and a low of ₹122.00 during the latest trading session. Over the past one year, MAITREYA MEDICARE LIMITED has delivered a loss of 48.18%, while the stock has declined 13.09% in the last one month.

    MAITREYA MEDICARE LIMITED performance

    Today’s low Today’s high
    ₹ 122.00 ₹ 131.40
    ₹ 125.45
    52 week low 52 week high
    ₹ 122.00 ₹ 292.95
    ₹ 125.45
    Open Price ₹ 122.65
    Prev. Close ₹ 126.75
    Volume (Shares) 3200.00
    Total traded value ₹ 4.01
    Upper Circuit ₹ 152.10
    Lower Circuit ₹ 101.40
    info

    Investment Returns

    Over 1 Month -13.09% Over 3 Months -24.64% Over 6 Months -35.07% Over 1 Year -48.18%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    MAITREYA MEDICARE LIMITED fundamentals


    • Market cap (Cr) 85.00
    • P/E Ratio (TTM) -65.00
    • Beta -0.30
    • Book Value / share 37.53
    • Return on equity 7.36%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -0.89
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    MAITREYA MEDICARE LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2024 (Values in Cr)
    Revenue 10.60
    Operating Expense 11.96
    Net Profit -0.89
    Net Profit Margin (%) -8.39
    Earnings Per Share (EPS) -1.34
    EBITDA -0.63
    Effective Tax Rate (%) 24.57
    Particulars DEC 2023 (Values in Cr)
    Revenue 11.65
    Operating Expense 9.53
    Net Profit 1.60
    Net Profit Margin (%) 13.73
    Earnings Per Share (EPS) 2.88
    EBITDA 2.55
    Effective Tax Rate (%) 24.64
    Particulars SEP 2023 (Values in Cr)
    Revenue 13.53
    Operating Expense 11.21
    Net Profit 1.84
    Net Profit Margin (%) 13.59
    Earnings Per Share (EPS) 3.53
    EBITDA 2.81
    Effective Tax Rate (%) 22.36
    Particulars JUN 2023 (Values in Cr)
    Revenue 10.75
    Operating Expense 0.00
    Net Profit 0.61
    Net Profit Margin (%) 5.67
    Earnings Per Share (EPS) 1.24
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 10.50
    Operating Expense 8.22
    Net Profit 1.79
    Net Profit Margin (%) 17.04
    Earnings Per Share (EPS) 2.69
    EBITDA 3.07
    Effective Tax Rate (%) 31.15
    Particulars MAR 2026 (Values in Cr)
    Revenue 44.22
    Operating Expense 46.18
    Net Profit -1.32
    Net Profit Margin (%) -2.98
    Earnings Per Share (EPS) -1.95
    EBITDA 1.31
    Effective Tax Rate (%) 1.49
    Particulars MAR 2025 (Values in Cr)
    Revenue 44.41
    Operating Expense 41.63
    Net Profit 1.90
    Net Profit Margin (%) 4.27
    Earnings Per Share (EPS) 2.80
    EBITDA 5.32
    Effective Tax Rate (%) 40.99
    Particulars MAR 2024 (Values in Cr)
    Revenue 46.53
    Operating Expense 42.36
    Net Profit 3.17
    Net Profit Margin (%) 6.81
    Earnings Per Share (EPS) 6.65
    EBITDA 6.39
    Effective Tax Rate (%) 27.56
    Particulars MAR 2023 (Values in Cr)
    Revenue 38.48
    Operating Expense 33.17
    Net Profit 3.30
    Net Profit Margin (%) 8.57
    Earnings Per Share (EPS) 6.65
    EBITDA 7.68
    Effective Tax Rate (%) 28.25
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 39.43
    ROE % 7.25
    ROCE % 10.95
    Total Debt to Total Equity 0.18
    EBITDA Margin 11.68
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 36.67
    ROE % 15.53
    ROCE % 17.87
    Total Debt to Total Equity 0.26
    EBITDA Margin 13.19
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 17.68
    ROE % 58.61
    ROCE % 34.66
    Total Debt to Total Equity 0.55
    EBITDA Margin 19.78
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 4711.12
    ROE % 19.84
    ROCE % 13.47
    Total Debt to Total Equity 0.90
    EBITDA Margin 7.49
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 3862.16
    ROE % 103.37
    ROCE % 36.13
    Total Debt to Total Equity 1.03
    EBITDA Margin 13.57
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 39.49
    ROE % 7.36
    ROCE % 11.36
    Total Debt to Total Equity 0.12
    EBITDA Margin 11.98
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 36.69
    ROE % 16.71
    ROCE % 18.73
    Total Debt to Total Equity 0.22
    EBITDA Margin 13.71
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 17.71
    ROE % 54.52
    ROCE % 33.53
    Total Debt to Total Equity 0.54
    EBITDA Margin 19.96
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 5485.40
    ROE % 21.70
    ROCE % 11.95
    Total Debt to Total Equity 0.84
    EBITDA Margin 6.99
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 4372.60
    ROE % 203.70
    ROCE % 44.04
    Total Debt to Total Equity 1.29
    EBITDA Margin 13.77
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 7.91
    Total Assets 47.99
    Total Liabilities 47.99
    Total Equity 32.85
    Share Outstanding 0
    Price to Book Ratio 7.74
    Return on Assets (%) 3.90
    Return on Capital (%) 4.92
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 6.55
    Total Assets 43.86
    Total Liabilities 43.86
    Total Equity 30.35
    Share Outstanding 0
    Price to Book Ratio 3.24
    Return on Assets (%) 6.77
    Return on Capital (%) 8.24
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.93
    Total Assets 28.91
    Total Liabilities 28.91
    Total Equity 15.54
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 14.70
    Return on Capital (%) 19.88
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.14
    Total Assets 24.48
    Total Liabilities 24.48
    Total Equity 10.87
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 4.64
    Return on Capital (%) 6.18
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 2.90
    Total Assets 25.27
    Total Liabilities 25.27
    Total Equity 9.59
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 16.79
    Return on Capital (%) 22.59
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.90
    Total Assets 44.41
    Total Liabilities 44.41
    Total Equity 32.07
    Share Outstanding 0
    Price to Book Ratio 7.74
    Return on Assets (%) 4.27
    Return on Capital (%) 5.33
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 5.66
    Total Assets 40.51
    Total Liabilities 40.51
    Total Equity 30.25
    Share Outstanding 0
    Price to Book Ratio 3.24
    Return on Assets (%) 7.83
    Return on Capital (%) 9.25
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.48
    Total Assets 27.74
    Total Liabilities 27.74
    Total Equity 14.51
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 15.08
    Return on Capital (%) 20.55
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.05
    Total Assets 22.83
    Total Liabilities 22.83
    Total Equity 10.36
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 4.66
    Return on Capital (%) 5.96
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.73
    Total Assets 25.89
    Total Liabilities 25.89
    Total Equity 9.42
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 17.02
    Return on Capital (%) 23.69
    Particulars MAR 2025 (Values in Cr)
    Net Income 3.21
    Cash from Operations 6.52
    Cash from Investing -7.37
    Cash from Financing 3.67
    Net change in Cash 1.35
    Free Cash Flow 8.90
    Particulars MAR 2024 (Values in Cr)
    Net Income 4.15
    Cash from Operations -0.73
    Cash from Investing -5.43
    Cash from Financing 12.20
    Net change in Cash 4.26
    Free Cash Flow 0.88
    Particulars MAR 2023 (Values in Cr)
    Net Income 5.95
    Cash from Operations 2.90
    Cash from Investing 0.36
    Cash from Financing -1.58
    Net change in Cash 1.36
    Free Cash Flow 2.93
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.59
    Cash from Operations 1.80
    Cash from Investing -0.01
    Cash from Financing -1.86
    Net change in Cash -1.80
    Free Cash Flow 2.70
    Particulars MAR 2021 (Values in Cr)
    Net Income 5.77
    Cash from Operations 5.60
    Cash from Investing -5.06
    Cash from Financing 2.16
    Net change in Cash 1.54
    Free Cash Flow 11.23
    Particulars MAR 2025 (Values in Cr)
    Net Income 3.22
    Cash from Operations 6.48
    Cash from Investing -7.20
    Cash from Financing -1.57
    Net change in Cash -3.75
    Free Cash Flow 8.85
    Particulars MAR 2024 (Values in Cr)
    Net Income 4.38
    Cash from Operations 1.51
    Cash from Investing -5.56
    Cash from Financing 10.00
    Net change in Cash 4.17
    Free Cash Flow 2.19
    Particulars MAR 2023 (Values in Cr)
    Net Income 5.87
    Cash from Operations 2.72
    Cash from Investing 0.35
    Cash from Financing -1.33
    Net change in Cash 1.43
    Free Cash Flow 2.75
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.41
    Cash from Operations 2.00
    Cash from Investing 0.16
    Cash from Financing -2.61
    Net change in Cash -1.67
    Free Cash Flow 2.90
    Particulars MAR 2021 (Values in Cr)
    Net Income 5.97
    Cash from Operations 5.12
    Cash from Investing -5.62
    Cash from Financing 1.51
    Net change in Cash 0.78
    Free Cash Flow 10.60
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8841.55 64.99 13.42 127127.92 6680.00 8948.10
    FORTIS MALAR HOSPITALS LIMITED 51.48 23.29 2.81 96.48 40.75 76.00
    SHREE PACETRONIX LTD. 152.05 18.14 3.20 57.01 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.08 0.00 2.78 23.34 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8841.55 84.68 12.75 127127.92 6680.00 8948.10
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 38.61 0.00 -9.39 28.84 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5981.10 26.77 4.95 6543.32 5010.00 6725.00

    MAITREYA MEDICARE LIMITED shareholding pattern

    Holding
    26.88%
    73.11%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    MAITREYA MEDICARE LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    125.45 -1.02 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 134.60
    • 26 Days 146.50
    • 10 Days 137.90
    • 50 Days 157.30
    • 12 Days 139.00
    • 100 Days 175.70
    • 20 Days 143.50
    • 200 Days 201.10
    136.35 PIVOT
    First Support 133.50 First Resistance 139.20 Second Support 130.65 Second Resistance 142.05 Third Support 127.80 Third Resistance 144.90
    RSI 39.43 ADX 54.37 MACD -6.85 Williams % R -84.05 Commodity Channel Index (CCI) -101.08
    Date 2026-07-10 Week 2000.00 Same Day 800.00 Month 2889.00
    1 Year -0.30 3 Year 0.30
    Over 1 Month
    -13.09% down
    Over 1 Year
    -48.18% down
    Over 3 Months
    -24.64% down
    Over 3 Years
    -4.06% down
    Over 6 Months
    -35.07% down
    Over 5 Years
    0.00% down

    MAITREYA MEDICARE LIMITED Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Maitreya Medicare Ltd?

    Answer Field

    Maitreya Medicare Ltd share price is for NSE ₹ 123.55 & for BSE ₹ 0.00 as on Jul 14 2026 03:27 PM.

    What is the Market Cap of Maitreya Medicare Ltd Share?

    Answer Field

    The market cap of Maitreya Medicare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 14 2026 03:27 PM.

    What is the 52 Week High and Low of Maitreya Medicare Ltd?

    Answer Field

    The 52 Week High and Low of Maitreya Medicare Ltd for NSE is ₹ 292.95 and ₹ 122.00 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Maitreya Medicare Ltd?

    Answer Field

    The 1 year returns on the stock has been -52.45%.

    What is the P/E Ratio of Maitreya Medicare Ltd Share?

    Answer Field

    As on Jul 14 2026 03:27 PM the price-to-earnings (PE) ratio for Maitreya Medicare Ltd share is -65.00.

    What is the PB ratio of Maitreya Medicare Ltd Share?

    Answer Field

    As on Jul 14 2026 03:27 PM, the price-to-book (PB) ratio for Maitreya Medicare Ltd share is 37.53.

    How to Buy Maitreya Medicare Ltd Share?

    Answer Field

    You can trade in Maitreya Medicare Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Maitreya Medicare Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Maitreya Medicare Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Maitreya Medicare Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |